학술논문
PP01.25 Incidence and Timing of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor as Monotherapy or in Combination With Chemotherapy
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology March 2023 18(3) Supplement:e21-e21
Subject
Language
ISSN
1556-0864